the efficacy and safety of a new antimycotic agent , ciclopirox olamine , were evaluated in two multicenter , randomized , double-blind trials in patients with clinically and mycologically diagnosed cutaneous candidosis .
C0126169
ciclopirox olamine
C0006846
cutaneous candidosis